Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 15.45
-0.35 (-2.22%)
Dec 5, 2025, 1:24 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.52 billion as of December 5, 2025. Its market cap has decreased by -35.18% in one year.
Market Cap
2.52B
Enterprise Value
3.64B
Revenue
113.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.45
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.52B, a decrease of -37.14%. That is a compound annual growth rate of -3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.52B | -30.88% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | 2.09B | 40.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |